CG Oncology, Inc. (CGON) Operating income 2023–2025
CG Oncology, Inc. (CGON) annual operating income history from SEC filings — each fiscal year as reported.
-$190.8MFY2025 · since FY2023: -$55.4M → -$190.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$190.8M | -66.4% |
| FY2024 | -$114.7M | -106.8% |
| FY2023 | -$55.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CGON financial trends
CGON RevenueCGON Net incomeCGON Net marginCGON Gross profitCGON Gross marginCGON Operating marginCGON Operating cash flowCGON Free cash flowCGON Capital expendituresCGON Return on equityCGON Stock buybacksCGON Dividends paidCGON Total assetsCGON Total liabilitiesCGON Shareholders’ equityCGON overview →